Riskpilot← Back to searchSign inGet full accessKlingemo Läkarpraktik AB
ABActiveOrg 5567416358Vikingavägen 12 BTranslation and interpretation activities · NACE 7430Est. 20072 employees
Revenue 2025
SEK 219K
-74% vs 2024
EBITDA margin
-61.0%
-123% vs 2024
Equity ratio
74.1%
Financial strength
Net profit 2025
SEK 39K
-90% vs 2024
| Revenue | SEK 219K | -74% |
| EBITDA | SEK -133K | -123% |
| Net profit | SEK 39K | -90% |
| Total assets | SEK 6M | +5% |
| Equity | SEK 4,5M | -6% |
| Employees | 2 | — |
Legal name
Klingemo Läkarpraktik AB
Org number
5567416358
Legal form
Aktiebolag
NACE code
7430 · Translation and interpretation activities
Founded
1 november 2007
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva läkarverksamhet och därmed förenlig verksamhet samt tolkverksamhet och juridisk hjälp och rådgivning.
Address
Vikingavägen 12 B
Email
viktorklingemo@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 788 | 2 031 | 1 146 | 855 | 219 |
| Staff expenses | — | — | −421 | −199 | −288 |
| EBITDA | 1 214 | 1 449 | 559 | 575 | −133 |
| Depreciation & amort. | −27 | −0 | — | — | — |
| EBIT | 1 187 | 1 449 | 559 | 575 | −133 |
| Net financials | — | — | 10 | 98 | 186 |
| Profit before tax | 892 | 1 089 | 428 | 503 | 53 |
| Tax | −190 | −225 | −91 | −107 | −14 |
| Net profit | 702 | 864 | 337 | 397 | 39 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 911 | 4 704 | 4 933 | 5 729 | 6 021 |
| Equity | 3 612 | 3 996 | 4 334 | 4 731 | 4 463 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 4 | 53 | −196 | 34 | 147 |
| Total debt | 4 | 53 | −196 | 34 | 147 |
EBITDA margin
-61.0%
This company
15.8%
Market median
-486% vs market
20212025
Equity ratio
74.1%
This company
38.2%
Market median
+94% vs market
20212025
Return on equity
0.9%
This company
18.4%
Market median
-95% vs market
20212025
Net profit margin
17.9%
This company
8.1%
Market median
+121% vs market
20212025
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Klingemo Läkarpraktik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Patric Christian Haddad | Deputy Board Member | 0 companies |
| Viktor Anatol Klingemo | Chairman | 0 companies |
| Claire Cleira Klingemo | Board of Directors | 0 companies |